ST
Stratec SE
STSEY · OTC
$5.51 +0.00% (+$0.00)
Market Cap 1.46B €
P/E Ratio -
Div. Yield 2.51%
ROE 0.14%
Bulios Fair Price
$3.19
42.1% downside
Current Price
$5.51
Undervalued Fair Value Overvalued
According to Bulios Fair Price, STSEY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
7 /100
Expensive P/S 5.95x
P/B 6.14x
P/FCF 61.33x
Growth
11 /100
Declining Book val. growth 1.77%
Rev. growth 2.97%
FCF growth N/A
Profitability
33 /100
Weak Net margin 0.13%
Op. margin 3.86%
FCF margin 9.70%
Quality
9 /100
Poor ROE 0.14%
ROA 0.08%
Asset turnover 0.60x
Debt
61 /100
Moderate Current ratio 4.23x
Int. coverage 2.27x
Net debt/EBITDA 2.99x
Stability
62 /100
Moderate Rev. volatility 1.52%
EPS volatility 62.92%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about STSEY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Marcus Wolfinger
Employees
1,403
Headquarters
Birkenfeld